Assignee
VALEANT PHARMACEUTICALS INT
US·7 granted patents·3 pending applications·71 citations·filing 2000–2014
Top patents by PatentIndex Score
10 records- 0188US7056895B2Tirazole nucleoside analogs and methods for using sameVALEANT PHARMACEUTICALS INT·Filed 2002·Granted Jun 6, 2006·39 cites·11 claims
- 0286US8859618B2Silicone gel-based compositions for wound healing and scar reductionVALEANT PHARMACEUTICALS INT·Filed 2013·Granted Oct 14, 2014·12 cites·17 claims
- 0383US7786146B2Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulatorsVALEANT PHARMACEUTICALS INT·Filed 2008·Granted Aug 31, 2010·7 cites·15 claims
- 0479US6743902B1Sugar modified nucleosidesVALEANT PHARMACEUTICALS INT·Filed 2000·Granted Jun 1, 2004·13 cites·18 claims
- 0558US2015037429A1Controlled Release MicroparticlesVALEANT PHARMACEUTICALS INT·Filed 2014·Application pending·0 cites
- 0656US7960436B2Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulatorsVALEANT PHARMACEUTICALS INT·Filed 2007·Granted Jun 14, 2011·0 cites·17 claims
- 0756US2008213218A1Method for treating hepatitis c virus infection in treatment failure patientsVALEANT PHARMACEUTICALS INT·Filed 2008·Application pending·0 cites
- 0850US8367684B2Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulatorsVALEANT PHARMACEUTICALS INT·Filed 2008·Granted Feb 5, 2013·0 cites·43 claims
- 0947US8030518B21,4 diamino bicyclic retigabine analogues as potassium channel modulatorsVALEANT PHARMACEUTICALS INT·Filed 2007·Granted Oct 4, 2011·0 cites·38 claims
- 1039US2010120906A1Modified release formulation and methods of useVALEANT PHARMACEUTICALS INT·Filed 2009·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →